Global DNA Sequencing and Service Market

DNA Sequencing and Service Comprehensive Study by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Others), Sequencing (Sanger Sequencing, Next-generation Sequencing, Others), End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics) Players and Region - Global Market Outlook to 2028

DNA Sequencing and Service Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About DNA Sequencing and Service
The DNA Sequencing Facility offers reliable, prolonged read, computerized Sanger sequencing with speedy turnaround; microsatellite-based genotyping and fragment analysis; plasmid and BAC DNA practise and purification; and related molecular natural choices which consists of PCR, cloning, sub-cloning, site-directed mutagenesis. DNA sequencing is a technological information in which a number DNA strands can be sequenced via giant parallelization. This sequencing consists of every Sanger’s approach of sequencing and non-Sanger’s techniques of sequencing. Advantages such as low cost, immoderate accuracy & speed, and unique effects even from low sample enter are supplied through way of DNA sequencing over microarray and extraordinary genomic comparison methods. DNA sequencing is used to execute a range of features such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide comparison and consists of substantially modified regular gear of genomics, frequently microarray, genotyping, and others. The demand for DNA sequencing has multiplied significantly, owing to surge in sequencing features and upward jab in technological traits in DNA sequencing.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The DNA sequencing market is fragmented, and the companies are deploying natural and inorganic boom techniques to compete in the market. Companies are attractive in launching modern market options to garner the interest of current and new customers. To make the most of the possibilities and get better from post-pandemic impact, market carriers must focal point greater on the increase potentialities in the fast-growing segments, whilst retaining their positions in the slow-growing segments. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global DNA Sequencing and Service market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Azenta US Inc. (United States), Becton Dickinson and Co. (United States), BGI Group (China), Bio Rad Laboratories Inc. (United States), Danaher Corp. (United States), Eurofins Scientific SE (Luxembourg), F. Hoffmann La Roche Ltd. (Switzerland) and Illumina Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Macrogen Inc. (South Korea), Merck KGaA (Germany), Pacific Biosciences of California Inc. (United States) and PerkinElmer Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global DNA Sequencing and Service market by , Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics and Others) and Region.



On the basis of geography, the market of DNA Sequencing and Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Sequencing by Synthesis will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sequencing, the sub-segment i.e. Sanger Sequencing will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Academic & Government Research Institutes will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
Increase in the Incidence of Genetic Disorders and Cancer, Declining Cost of Genetic Sequencing and Technological Advancements in Sequencing Techniques

Challenges:
Inadequate Resources for DNA Sequencing In Developing Countries

Restraints:
Lack of Skilled Personnel and High Costs Incurred In the Establishment and Maintenance of Sequencing Facilities

Opportunities:
Use of genomics in specialized/personalized medicine

Market Leaders and their expansionary development strategies
In2020, QIAGEN (Netherlands) obtained NeuMoDx Molecular (US) to improve its management role in computerized molecular testing. Medium- and high-throughput NeuMoDx automation options based totally on PCR checking out technological know-how will now be built-in into QIAGEN’s portfolio.
In August 2020, Illumina Inc. launched NovaSeq 6000 v1.5 Reagent Kit, which made the WGS method extra reasonably priced and reachable for all the laboratories and decreased the price to sequence a human genome for USD 600. These new kits can be used throughout WGS, single-cell genomics, and liquid biopsy techniques.
In January 2020, the Department of Biotechnology (DBT) initiated the “Genome India Project” (GIP). The challenge ambitions to gather 10,000 genetic samples from residents throughout India to construct a reference genome. Some of the areas of center of attention of this challenge are precision health, uncommon genetic disorders, mutation spectrum of genetic and complicated ailments in the Indian population, genetic epidemiology of multifactorial way of life diseases, and translational research.

Key Target Audience
DNA Sequencing and Service Provider, Academic & Government Research Institutes, Pharmaceutical Companies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Diagnostics
  • Biomarkers & Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Others
By Technology
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Others

By Sequencing
  • Sanger Sequencing
  • Next-generation Sequencing
  • Others

By End User
  • Academic & Government Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Incidence of Genetic Disorders and Cancer
      • 3.2.2. Declining Cost of Genetic Sequencing
      • 3.2.3. Technological Advancements in Sequencing Techniques
    • 3.3. Market Challenges
      • 3.3.1. Inadequate Resources for DNA Sequencing In Developing Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global DNA Sequencing and Service, by Application, Technology, Sequencing, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global DNA Sequencing and Service (Value)
      • 5.2.1. Global DNA Sequencing and Service by: Application (Value)
        • 5.2.1.1. Diagnostics
        • 5.2.1.2. Biomarkers & Cancer
        • 5.2.1.3. Reproductive Health
        • 5.2.1.4. Personalized Medicine
        • 5.2.1.5. Forensics
        • 5.2.1.6. Others
      • 5.2.2. Global DNA Sequencing and Service by: Technology (Value)
        • 5.2.2.1. Sequencing by Synthesis
        • 5.2.2.2. Ion Semiconductor Sequencing
        • 5.2.2.3. Sequencing by Ligation
        • 5.2.2.4. Pyrosequencing
        • 5.2.2.5. Others
      • 5.2.3. Global DNA Sequencing and Service by: Sequencing (Value)
        • 5.2.3.1. Sanger Sequencing
        • 5.2.3.2. Next-generation Sequencing
        • 5.2.3.3. Others
      • 5.2.4. Global DNA Sequencing and Service by: End User (Value)
        • 5.2.4.1. Academic & Government Research Institutes
        • 5.2.4.2. Pharmaceutical Companies
        • 5.2.4.3. Biotechnology Companies
        • 5.2.4.4. Hospitals & Clinics
      • 5.2.5. Global DNA Sequencing and Service Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. DNA Sequencing and Service: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Azenta US Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Becton Dickinson and Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BGI Group (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio Rad Laboratories Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Danaher Corp. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Eurofins Scientific SE (Luxembourg)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann La Roche Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Illumina Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global DNA Sequencing and Service Sale, by Application, Technology, Sequencing, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global DNA Sequencing and Service (Value)
      • 7.2.1. Global DNA Sequencing and Service by: Application (Value)
        • 7.2.1.1. Diagnostics
        • 7.2.1.2. Biomarkers & Cancer
        • 7.2.1.3. Reproductive Health
        • 7.2.1.4. Personalized Medicine
        • 7.2.1.5. Forensics
        • 7.2.1.6. Others
      • 7.2.2. Global DNA Sequencing and Service by: Technology (Value)
        • 7.2.2.1. Sequencing by Synthesis
        • 7.2.2.2. Ion Semiconductor Sequencing
        • 7.2.2.3. Sequencing by Ligation
        • 7.2.2.4. Pyrosequencing
        • 7.2.2.5. Others
      • 7.2.3. Global DNA Sequencing and Service by: Sequencing (Value)
        • 7.2.3.1. Sanger Sequencing
        • 7.2.3.2. Next-generation Sequencing
        • 7.2.3.3. Others
      • 7.2.4. Global DNA Sequencing and Service by: End User (Value)
        • 7.2.4.1. Academic & Government Research Institutes
        • 7.2.4.2. Pharmaceutical Companies
        • 7.2.4.3. Biotechnology Companies
        • 7.2.4.4. Hospitals & Clinics
      • 7.2.5. Global DNA Sequencing and Service Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. DNA Sequencing and Service: by Application(USD Million)
  • Table 2. DNA Sequencing and Service Diagnostics , by Region USD Million (2017-2022)
  • Table 3. DNA Sequencing and Service Biomarkers & Cancer , by Region USD Million (2017-2022)
  • Table 4. DNA Sequencing and Service Reproductive Health , by Region USD Million (2017-2022)
  • Table 5. DNA Sequencing and Service Personalized Medicine , by Region USD Million (2017-2022)
  • Table 6. DNA Sequencing and Service Forensics , by Region USD Million (2017-2022)
  • Table 7. DNA Sequencing and Service Others , by Region USD Million (2017-2022)
  • Table 8. DNA Sequencing and Service: by Technology(USD Million)
  • Table 9. DNA Sequencing and Service Sequencing by Synthesis , by Region USD Million (2017-2022)
  • Table 10. DNA Sequencing and Service Ion Semiconductor Sequencing , by Region USD Million (2017-2022)
  • Table 11. DNA Sequencing and Service Sequencing by Ligation , by Region USD Million (2017-2022)
  • Table 12. DNA Sequencing and Service Pyrosequencing , by Region USD Million (2017-2022)
  • Table 13. DNA Sequencing and Service Others , by Region USD Million (2017-2022)
  • Table 14. DNA Sequencing and Service: by Sequencing(USD Million)
  • Table 15. DNA Sequencing and Service Sanger Sequencing , by Region USD Million (2017-2022)
  • Table 16. DNA Sequencing and Service Next-generation Sequencing , by Region USD Million (2017-2022)
  • Table 17. DNA Sequencing and Service Others , by Region USD Million (2017-2022)
  • Table 18. DNA Sequencing and Service: by End User(USD Million)
  • Table 19. DNA Sequencing and Service Academic & Government Research Institutes , by Region USD Million (2017-2022)
  • Table 20. DNA Sequencing and Service Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 21. DNA Sequencing and Service Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 22. DNA Sequencing and Service Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 23. South America DNA Sequencing and Service, by Country USD Million (2017-2022)
  • Table 24. South America DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 25. South America DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 26. South America DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 27. South America DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 28. Brazil DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 29. Brazil DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 30. Brazil DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 31. Brazil DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 32. Argentina DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 33. Argentina DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 34. Argentina DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 35. Argentina DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 36. Rest of South America DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 37. Rest of South America DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 38. Rest of South America DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 39. Rest of South America DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 40. Asia Pacific DNA Sequencing and Service, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 43. Asia Pacific DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 44. Asia Pacific DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 45. China DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 46. China DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 47. China DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 48. China DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 49. Japan DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 50. Japan DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 51. Japan DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 52. Japan DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 53. India DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 54. India DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 55. India DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 56. India DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 57. South Korea DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 58. South Korea DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 59. South Korea DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 60. South Korea DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 61. Australia DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 62. Australia DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 63. Australia DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 64. Australia DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 69. Europe DNA Sequencing and Service, by Country USD Million (2017-2022)
  • Table 70. Europe DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 71. Europe DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 72. Europe DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 73. Europe DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 74. Germany DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 75. Germany DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 76. Germany DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 77. Germany DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 78. France DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 79. France DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 80. France DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 81. France DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 82. Italy DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 83. Italy DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 84. Italy DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 85. Italy DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 86. United Kingdom DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 87. United Kingdom DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 88. United Kingdom DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 89. United Kingdom DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 90. Netherlands DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 91. Netherlands DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 92. Netherlands DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 93. Netherlands DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 94. Rest of Europe DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 95. Rest of Europe DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 96. Rest of Europe DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 97. Rest of Europe DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 98. MEA DNA Sequencing and Service, by Country USD Million (2017-2022)
  • Table 99. MEA DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 100. MEA DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 101. MEA DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 102. MEA DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 103. Middle East DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 104. Middle East DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 105. Middle East DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 106. Middle East DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 107. Africa DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 108. Africa DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 109. Africa DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 110. Africa DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 111. North America DNA Sequencing and Service, by Country USD Million (2017-2022)
  • Table 112. North America DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 113. North America DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 114. North America DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 115. North America DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 116. United States DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 117. United States DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 118. United States DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 119. United States DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 120. Canada DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 121. Canada DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 122. Canada DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 123. Canada DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 124. Mexico DNA Sequencing and Service, by Application USD Million (2017-2022)
  • Table 125. Mexico DNA Sequencing and Service, by Technology USD Million (2017-2022)
  • Table 126. Mexico DNA Sequencing and Service, by Sequencing USD Million (2017-2022)
  • Table 127. Mexico DNA Sequencing and Service, by End User USD Million (2017-2022)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. DNA Sequencing and Service: by Application(USD Million)
  • Table 139. DNA Sequencing and Service Diagnostics , by Region USD Million (2023-2028)
  • Table 140. DNA Sequencing and Service Biomarkers & Cancer , by Region USD Million (2023-2028)
  • Table 141. DNA Sequencing and Service Reproductive Health , by Region USD Million (2023-2028)
  • Table 142. DNA Sequencing and Service Personalized Medicine , by Region USD Million (2023-2028)
  • Table 143. DNA Sequencing and Service Forensics , by Region USD Million (2023-2028)
  • Table 144. DNA Sequencing and Service Others , by Region USD Million (2023-2028)
  • Table 145. DNA Sequencing and Service: by Technology(USD Million)
  • Table 146. DNA Sequencing and Service Sequencing by Synthesis , by Region USD Million (2023-2028)
  • Table 147. DNA Sequencing and Service Ion Semiconductor Sequencing , by Region USD Million (2023-2028)
  • Table 148. DNA Sequencing and Service Sequencing by Ligation , by Region USD Million (2023-2028)
  • Table 149. DNA Sequencing and Service Pyrosequencing , by Region USD Million (2023-2028)
  • Table 150. DNA Sequencing and Service Others , by Region USD Million (2023-2028)
  • Table 151. DNA Sequencing and Service: by Sequencing(USD Million)
  • Table 152. DNA Sequencing and Service Sanger Sequencing , by Region USD Million (2023-2028)
  • Table 153. DNA Sequencing and Service Next-generation Sequencing , by Region USD Million (2023-2028)
  • Table 154. DNA Sequencing and Service Others , by Region USD Million (2023-2028)
  • Table 155. DNA Sequencing and Service: by End User(USD Million)
  • Table 156. DNA Sequencing and Service Academic & Government Research Institutes , by Region USD Million (2023-2028)
  • Table 157. DNA Sequencing and Service Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 158. DNA Sequencing and Service Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 159. DNA Sequencing and Service Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 160. South America DNA Sequencing and Service, by Country USD Million (2023-2028)
  • Table 161. South America DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 162. South America DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 163. South America DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 164. South America DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 165. Brazil DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 166. Brazil DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 167. Brazil DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 168. Brazil DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 169. Argentina DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 170. Argentina DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 171. Argentina DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 172. Argentina DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 173. Rest of South America DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 174. Rest of South America DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 175. Rest of South America DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 176. Rest of South America DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 177. Asia Pacific DNA Sequencing and Service, by Country USD Million (2023-2028)
  • Table 178. Asia Pacific DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 179. Asia Pacific DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 180. Asia Pacific DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 181. Asia Pacific DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 182. China DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 183. China DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 184. China DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 185. China DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 186. Japan DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 187. Japan DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 188. Japan DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 189. Japan DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 190. India DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 191. India DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 192. India DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 193. India DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 194. South Korea DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 195. South Korea DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 196. South Korea DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 197. South Korea DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 198. Australia DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 199. Australia DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 200. Australia DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 201. Australia DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 202. Rest of Asia-Pacific DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 203. Rest of Asia-Pacific DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 204. Rest of Asia-Pacific DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 205. Rest of Asia-Pacific DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 206. Europe DNA Sequencing and Service, by Country USD Million (2023-2028)
  • Table 207. Europe DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 208. Europe DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 209. Europe DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 210. Europe DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 211. Germany DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 212. Germany DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 213. Germany DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 214. Germany DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 215. France DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 216. France DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 217. France DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 218. France DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 219. Italy DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 220. Italy DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 221. Italy DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 222. Italy DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 223. United Kingdom DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 224. United Kingdom DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 225. United Kingdom DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 226. United Kingdom DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 227. Netherlands DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 228. Netherlands DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 229. Netherlands DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 230. Netherlands DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 231. Rest of Europe DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 232. Rest of Europe DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 233. Rest of Europe DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 234. Rest of Europe DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 235. MEA DNA Sequencing and Service, by Country USD Million (2023-2028)
  • Table 236. MEA DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 237. MEA DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 238. MEA DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 239. MEA DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 240. Middle East DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 241. Middle East DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 242. Middle East DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 243. Middle East DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 244. Africa DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 245. Africa DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 246. Africa DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 247. Africa DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 248. North America DNA Sequencing and Service, by Country USD Million (2023-2028)
  • Table 249. North America DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 250. North America DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 251. North America DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 252. North America DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 253. United States DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 254. United States DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 255. United States DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 256. United States DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 257. Canada DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 258. Canada DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 259. Canada DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 260. Canada DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 261. Mexico DNA Sequencing and Service, by Application USD Million (2023-2028)
  • Table 262. Mexico DNA Sequencing and Service, by Technology USD Million (2023-2028)
  • Table 263. Mexico DNA Sequencing and Service, by Sequencing USD Million (2023-2028)
  • Table 264. Mexico DNA Sequencing and Service, by End User USD Million (2023-2028)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global DNA Sequencing and Service: by Application USD Million (2017-2022)
  • Figure 5. Global DNA Sequencing and Service: by Technology USD Million (2017-2022)
  • Figure 6. Global DNA Sequencing and Service: by Sequencing USD Million (2017-2022)
  • Figure 7. Global DNA Sequencing and Service: by End User USD Million (2017-2022)
  • Figure 8. South America DNA Sequencing and Service Share (%), by Country
  • Figure 9. Asia Pacific DNA Sequencing and Service Share (%), by Country
  • Figure 10. Europe DNA Sequencing and Service Share (%), by Country
  • Figure 11. MEA DNA Sequencing and Service Share (%), by Country
  • Figure 12. North America DNA Sequencing and Service Share (%), by Country
  • Figure 13. Global DNA Sequencing and Service share by Players 2022 (%)
  • Figure 14. Global DNA Sequencing and Service share by Players (Top 3) 2022(%)
  • Figure 15. Global DNA Sequencing and Service share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 19. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Agilent Technologies Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Azenta US Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Azenta US Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Becton Dickinson and Co. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton Dickinson and Co. (United States) Revenue: by Geography 2022
  • Figure 25. BGI Group (China) Revenue, Net Income and Gross profit
  • Figure 26. BGI Group (China) Revenue: by Geography 2022
  • Figure 27. Bio Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Bio Rad Laboratories Inc. (United States) Revenue: by Geography 2022
  • Figure 29. Danaher Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Danaher Corp. (United States) Revenue: by Geography 2022
  • Figure 31. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 32. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2022
  • Figure 33. F. Hoffmann La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F. Hoffmann La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 35. Illumina Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Illumina Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Global DNA Sequencing and Service: by Application USD Million (2023-2028)
  • Figure 38. Global DNA Sequencing and Service: by Technology USD Million (2023-2028)
  • Figure 39. Global DNA Sequencing and Service: by Sequencing USD Million (2023-2028)
  • Figure 40. Global DNA Sequencing and Service: by End User USD Million (2023-2028)
  • Figure 41. South America DNA Sequencing and Service Share (%), by Country
  • Figure 42. Asia Pacific DNA Sequencing and Service Share (%), by Country
  • Figure 43. Europe DNA Sequencing and Service Share (%), by Country
  • Figure 44. MEA DNA Sequencing and Service Share (%), by Country
  • Figure 45. North America DNA Sequencing and Service Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Agilent Technologies Inc. (United States)
  • Azenta US Inc. (United States)
  • Becton Dickinson and Co. (United States)
  • BGI Group (China)
  • Bio Rad Laboratories Inc. (United States)
  • Danaher Corp. (United States)
  • Eurofins Scientific SE (Luxembourg)
  • F. Hoffmann La Roche Ltd. (Switzerland)
  • Illumina Inc. (United States)
Additional players considered in the study are as follows:
Macrogen Inc. (South Korea) , Merck KGaA (Germany) , Pacific Biosciences of California Inc. (United States) , PerkinElmer Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 228 Pages 62 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global DNA Sequencing and Service Market Quantitative research analysis
Global DNA Sequencing and Service Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Azenta US Inc. (United States), Becton Dickinson and Co. (United States), BGI Group (China), Bio Rad Laboratories Inc. (United States), Danaher Corp. (United States), Eurofins Scientific SE (Luxembourg), F. Hoffmann La Roche Ltd. (Switzerland) and Illumina Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for DNA Sequencing and Service Market during projected period 2022-2028.
The DNA Sequencing and Service market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global DNA Sequencing and Service Market Report?

Have a Query? Click Here

Other Related Reports

Hydrogel Drug Delivery Systems Comprehensive Study by Application (Healthcare, Hygiene, Contact Lenses, Tissue Engineering, Others), Composition (Silicon Hydrogel, Polyacrylate, Polyacrylamide), Hyd...
$ 3500
Dog Cloning- Comprehensive Study by Type (Gene Cloning, Reproductive Cloning, Therapeutic Cloning), Application (Companion Dogs, Service Dogs, Others), Species (Endangered Species, Extinct Species) P...
$ 3800
Reproductive Genetics Comprehensive Study by Type (Laboratory Developed Tests (LDT), Kits, Reagents and Consumables), Application (Aneuploidy, Single Gene Disorders, Structural Abnormalities, Others)...
$ 3800
Smart Aquaculture Systems Comprehensive Study by Application (Fish, Crab, Shrimp, Others), System (Closed System, Open System), Aquaculture (Marine, Freshwater) Players and Region - Global Market Out...
$ 3500
Insect Biotechnology Comprehensive Study by Application (Biochemical Recycling, Pollination, Biological Control, Pest Management, Gene Therapy, Other), Technique (Recombinant DNA Technology, Transgen...
$ 3800
microRNA Based Diagnostic Kit Comprehensive Study by Mode of Delivery (Conjugation, Virus-Associated Delivery, Nanoparticles), End Use (Hospitals and Clinics, Diagnostic Laboratories, Academic & Gove...
$ 3800